{"transactions":[{"id":766380,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-22T21:32:19.000Z","date":"2026-05-21","kind":"other","planned":false,"acquired":false,"shares":1604,"price":4.47,"value":7169.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award made on May 21, 2024."}],"balance_after":414801,"source":{"system":"sec-edgar","filing":"0001079973-26-000723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000723/ownership.xml","form_type":"4"}},{"id":823177,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:47:21.000Z","date":"2026-03-27","kind":"other","planned":false,"acquired":false,"shares":20320,"price":3.07,"value":62382.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 31, 2026"}],"balance_after":416405,"source":{"system":"sec-edgar","filing":"0001079973-26-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000440/ownership.xml","form_type":"4"}},{"id":823176,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-02T00:47:21.000Z","date":"2026-03-27","kind":"grant","planned":false,"acquired":false,"shares":202914,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":436725,"source":{"system":"sec-edgar","filing":"0001079973-26-000440","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000440/ownership.xml","form_type":"4"}},{"id":835404,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:20:19.000Z","date":"2026-03-17","kind":"other","planned":false,"acquired":false,"shares":1314,"price":3.59,"value":4717.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on March 17, 2026."}],"balance_after":233811,"source":{"system":"sec-edgar","filing":"0001079973-26-000330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000330/ownership.xml","form_type":"4"}},{"id":947342,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:02.000Z","date":"2026-01-02","kind":"other","planned":false,"acquired":false,"shares":244,"price":3.67,"value":895.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on January 1, 2026."}],"balance_after":235125,"source":{"system":"sec-edgar","filing":"0001079973-26-000039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000039/ownership.xml","form_type":"4/A","original_submission_date":"2026-01-05"}},{"id":952312,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T22:04:59.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":247,"price":3.56,"value":879.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person used the proceeds of this sale to cover tax liabilities arising from the vesting of an RSU award on January 1, 2026."}],"balance_after":235122,"source":{"system":"sec-edgar","filing":"0001079973-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997326000008/ownership.xml","form_type":"4"}},{"id":994223,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-19T23:00:18.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards that were fully vested upon grant, net of withholding tax obligations."}],"balance_after":235369,"source":{"system":"sec-edgar","filing":"0001079973-25-001805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997325001805/ownership.xml","form_type":"4"}},{"id":1137593,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-22T18:12:47.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1601,"price":2.675,"value":4282.675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."}],"balance_after":235174,"source":{"system":"sec-edgar","filing":"0001628280-25-027205","document":"wk-form4_1747937561.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000162828025027205/wk-form4_1747937561.xml","form_type":"4"}},{"id":1184085,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-02T21:22:47.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":197368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSU awards with 1/4th of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates."}],"balance_after":236775,"source":{"system":"sec-edgar","filing":"0001799191-25-000021","document":"wk-form4_1743628960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000179919125000021/wk-form4_1743628960.xml","form_type":"4"}},{"id":1188984,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Warrant","published_at":"2025-03-28T21:27:58.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":4528,"price":0.125,"value":566.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act."}],"balance_after":4528,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":4528},"source":{"system":"sec-edgar","filing":"0001079973-25-000515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997325000515/ownership.xml","form_type":"4"}},{"id":1188983,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-28T21:27:58.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":9056,"price":1.0417,"value":9433.6352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."}],"balance_after":39407,"source":{"system":"sec-edgar","filing":"0001079973-25-000515","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000107997325000515/ownership.xml","form_type":"4"}},{"id":1195939,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-20T21:56:42.000Z","date":"2025-03-19","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1150,"price":0.889,"value":1022.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."}],"balance_after":30351,"source":{"system":"sec-edgar","filing":"0001799191-25-000006","document":"wk-form4_1742507796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000179919125000006/wk-form4_1742507796.xml","form_type":"4"}},{"id":1308449,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-01-07T18:18:13.000Z","date":"2025-01-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":258,"price":0.335,"value":86.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average selling price of all sales by the Reporting Person on January 6, 2025 within a one-dollar range. Actual prices ranged from $0.293 to $0.335. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":31501,"source":{"system":"sec-edgar","filing":"0001799191-25-000002","document":"wk-form4_1736273886.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000179919125000002/wk-form4_1736273886.xml","form_type":"4"}},{"id":1356079,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":44812,"kind":"person","name":"Carter Robert Ross","position":1,"cik":"0002039341","reported_name":"Carter Robert Ross","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-11-21T23:21:51.000Z","date":"2024-11-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":235,"price":0.136,"value":31.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is the volume weighted average selling price of all sales by the Reporting Person on November 20, 2024 within a one-dollar range. Actual prices ranged from $0.136 to $0.168. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price."}],"balance_after":31759,"source":{"system":"sec-edgar","filing":"0001799191-24-000042","document":"wk-form4_1732231303.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039341/000179919124000042/wk-form4_1732231303.xml","form_type":"4"}}]}